Quoin Pharmaceuticals Ltd

QNRX

Company Profile

  • Business description

    Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

  • Contact

    42127 Pleasant Forest Court
    AshburnVA20148-7349
    USA

    T: +1 703 980-4182

    https://www.quoinpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    3

Stocks News & Analysis

stocks

Investment decisions in overvalued bank drive strong results

Shares fall despite a broadly unchanged outlook.
stocks

Overvalued ASX share hurt by normalising conditions

Investors overly optimisitc about future prospects.
stocks

After earnings, is Amazon stock a buy, a sell, or fairly valued?

With temperature on tariffs easing and a raised fair value estimate, here’s what we think of Amazon’s results.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,083.3026.400.29%
CAC 407,950.1814.59-0.18%
DAX 4023,569.96164.06-0.69%
Dow JONES (US)46,987.1074.800.16%
FTSE 1009,682.5753.21-0.55%
HKSE26,241.83244.07-0.92%
NASDAQ23,004.5449.46-0.21%
Nikkei 22550,692.57416.200.83%
NZX 50 Index13,562.0637.15-0.27%
S&P 5006,728.808.480.13%
S&P/ASX 2008,809.3017.500.20%
SSE Composite Index3,996.531.02-0.03%

Market Movers